The abnormal maturation and ossifi cation of articular chondrocytes play a central role in the pathogenesis of osteoarthritis (OA). Inhibiting the enzymatic degradation of the extracellular matrix and maintaining the cellular phenotype are two of the major goals of interest in managing OA. Ginseng is frequently taken orally, as a crude substance, as a traditional medicine in Asian countries. Ginsenoside Rb 1 , a major component of ginseng that contains an aglycone with a dammarane skeleton, has been reported to exhibit various biological activities, including anti-infl ammatory and anti-tumor effects. However, a chondroprotective effect of ginsenoside Rb 1 related to OA has not yet been reported. The purpose of this study was to demonstrate the chondroprotective effect of ginsenoside Rb 1 on the regulation of pro-infl ammatory factors and chondrogenic genes. Cultured rat articular chondrocytes were treated with 100 μM ginsenoside Rb 1 and/or 500 μM hydrogen peroxide (H 2 O 2 ) and assessed for viability, reactive oxygen species production, nitric oxide (NO) release, and chondrogenic gene expression. Ginsenoside Rb 1 treatment resulted in reductions in the levels of pro-infl ammatory cytokine and NO in H 2 O 2 -treated chondrocytes. The expression levels of chondrogenic genes, such as type II collagen and SOX9, were increased in the presence of ginsenoside Rb 1 , whereas the expression levels of infl ammatory genes related to chondrocytes, such as MMP1 and MMP13, were reduced by approximately 50%. These results suggest that ginsenoside Rb 1 has potential for use as a therapeutic agent in OA patients.
INTRODUCTION
Osteoarthritis (OA) is one of the most prevalent chronic diseases affecting the elderly and is a major degenerative disease affecting millions of individuals. The most prominent feature of OA is the progressive destruction of articular cartilage, and it is now accepted that OA is a global disease involving synovial membranes, subchondral bone, and periarticular soft tissues [1] . Today, in the search for a cure for OA, the inhibition of the enzymatic degradation of the extracellular matrix (ECM) and the maintenance of the cellular phenotype are two of the major goals in OA research [2, 3] .
Hydrogen peroxide (H 2 O 2 ) has a variety of biological effects on various cell types. In chondrocytes, H 2 O 2 inhibits proteoglycan synthesis and induces the degrada-tion of the ECM [4] . H 2 O 2 is also related to aggrecan degradation in bovine articular chondrocytes [5] . H 2 O 2 induces the expression of the inflammatory cytokines interleukin (IL)-1β and tumor necrosis factor (TNF)-α, which exert negative effects on the expression of matrix metalloproteinases (MMPs) and transforming growth factor (TGF)-β1 [6] . Furthermore, H 2 O 2 may produce reactive oxygen species (ROS) and nitric oxygen (NO) species in addition to inducing the apoptosis of chondrocytes [7] . Thus, H 2 O 2 may be an important factor involved in the pathology of OA. Free radicals are related to many chronic infl ammatory diseases [4] . Many studies have shown that free radicals play an important role in the pathology of OA [5] [6] [7] [8] . Among the various ROS and NO that exist, H 2 O 2 is an important intermediate in superoxide anion metabolism. H 2 O 2 is formed from the superoxide anion by superoxide dismutase and is removed by glutathione peroxidase and catalase [9] . Recent studies show that the activity of catalase in OA joints is decreased [10] and that the accumulation H 2 O 2 in arthritic joints is expected [11] . Therefore, antioxidants that protect against free radicals such as H 2 O 2 are valuable for the protection of chondrocytes by blocking the catabolic signaling cascades that are triggered by infl ammatory cytokines and free radical stimulation.
Ginseng is a rich source of ginsenosides, and several epidemiological and animal studies have shown that ginseng consumption is associated with health benefits, including the inhibition of infl ammation [12] . Most of the benefi cial health effects of ginseng have been shown to be mediated by most prevalent component, ginsenoside. Ginsenoside infl uences a number of cellular mechanisms and has been shown to inhibit the activities of IL-1β and TNF-α [13] . In addition, ginsenoside Rb 1 is also an inhibitor of ROS and NO activity and downregulates the levels of several markers of oxidative stress [13] . Despite several studies in the literature detailing the antioxidant effects of ginsenoside Rb 1 , the mechanisms underlying protective effects at the chondrocyte cellular level have not been reported. In this study, we evaluated the protective effects of ginsenoside Rb 1 on rat articular chondrocytes and the molecular mechanisms involved in the protection.
MATERIALS AND METHODS

Harvesting chondrocytes and establishing cell cultures
A modified method for harvesting chondrocytes was used as previously described [14] . Briefl y, chondrocytes were isolated from the articular cartilage of three-weekold male Sprague Dawley rats. Cartilage was removed from animals that were subsequently euthanized by an overdose of anesthesia. The cartilage was cut into thin slices, washed with sterilized phosphate-buffered saline (PBS), and soaked in 5% penicillin-streptomycinneomycin (Sigma, St. Louis, MO, USA) for 15 min. The cartilage slices were washed with PBS to remove residual antibiotic solution and digested with 0.02% type II collagenase (Sigma) in Dulbecco's Modified Eagle's Medium (DMEM; HyClone, Logan, UT, USA) for 3 h in a 37°C water bath. The digested cartilage was collected and centrifuged. The pellet was resuspended in DMEM and filtered through 70-μm nylon mesh. The resultant chondrocytes were cultured in DMEM supplement with 10% fetal bovine serum and 1% penicillin-streptomycin-neomycin in a 5% CO 2 incubator at 37°C. All experiments were performed when cells reached confluence within the fi rst passage. Ginsenoside Rb 1 was purchased from Ambo Institute (Daejeon, Korea).
Cell viability assay
The water soluble tetrazolium cell proliferation assay was used to measure cell viability by calculating the quantitative absorbance of formazan using an EZ-Cytox Cell Viability Assay Kit (DAEIL lab, Seoul, Korea). The EZ-Cytox agent is converted into orange formazan by the mitochondria of active cells. The amount of orange product increases with an increase in cell activity and can be quantifi ed using a spectrophotometer. Cells were plated in 96-well plates at a density of 2.0×10 4 cells per well, incubated for 24 h and treated with various concentrations (25 to 400 μM) of ginsenoside Rb 1 . We then determined whether a 1-hour pretreatment with ginsenoside Rb 1 (50 or 100 μM) infl uenced the viability of chondrocytes treated with 500 μM H 2 O 2 for 24 h. After the incubation period, 10 μL of the kit solution was added to each well, and the cells were incubated for 3 h at 37°C in 5% CO 2 . The index of cell viability was determined by measuring formazan production with a microplate reader at an absorbance of 480 nm and a reference wavelength of 650 nm.
Enzyme-linked immunosorbent assay
The concentrations of IL-1β and TNF-α in the supernatants were determined by enzyme-linked immunosorbent assay (ELISA) using a kit (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions. The detection limit of the assay was 1.6 pg/mL.
Intracellular reactive oxygen species assay
The level of intracellular ROS was quantified by fluorescence using dichlorofluorescein diacetate (DCF-DA, Invitrogen). Chondrocytes plated in a 48-well plate were left untreated or were pretreated for 1 h with 50 or 100 μM ginsenoside Rb 1 in the absence or presence of H 2 O 2 , and then the cells were incubated for 0.5 h. After the incubation period, the cells were washed with PBS and stained with 10 μM DCF-DA in PBS for 30 min in the dark. The cells were then washed twice with PBS and extracted with 0.1% Tween-20 in PBS for 10 min at 37°C. Fluorescence was recorded with an excitation wavelength of 490 nm and an emission wavelength of 525 nm.
Nitric oxygen production and activity of inducible nitric oxide synthase
The concentration of NO was measured by the Griess reaction. A 20 μL sample of culture medium supernatant was mixed with 180 μL of Griess reagent at room temperature for 10 min, and then the absorbance was measured in a microplate reader at 570 nm. The activity of inducible nitric oxide synthase (iNOS) was analyzed by immunoblotting. Briefl y, total cell extracts were harvested in radioimmunoprecipitation assay buffer and then centrifuged at 15,000 rpm for 15 min at 4°C. Quantifi cation of the total protein was performed with bicinchoninic acid protein assay reagent (Bio-Rad Laboratories, Hercules, CA, USA). Proteins were resolved with sodium dodecyl sulfate polyacrylamide gel electrophoresis at 10% and transferred to a polyvinylidene difluoride membrane. After blocking in 5% skim milk in PBS with 0.1% Tween-20 (PBS-T), the membrane was incubated with specific primary antibodies for iNOS and β-actin (Cell Signaling, Danvers, MA, USA) diluted 1:1,000 in 1% skim milk in PBS-T overnight at 4°C. After washing, the blots were incubated at room temperature for 1 h with a peroxidase-conjugated goat anti-rabbit IgG secondary antibody (Millipore, Bedford, MA, USA) diluted 1:10,000 in PBS-T. The signals were detected with a SuperSignal West Dura Extended Duration Substrate (Thermo Scientific, San Jose, CA, USA), according to the manufacturer's instructions. Densitometric analysis was conducted directly using the blotted membrane utilizing a ChemiImager analyzer system (Alpha Innotech, San Leandro, CA, USA).
RNA preparation and real-time reverse transcription polymerase chain reaction
Total cellular RNA was precipitated with Ribo EX (GeneAll, Daejeon, Korea) and dissolved in 0.1% diethylpyrocarbonate-treated distilled water. Total RNA (2 μg) was treated with RNase-free DNase (Invitrogen), and fi rst-strand cDNA was generated using the oligo primers provided in a fi rst-strand cDNA synthesis kit, (Maxime RT PreMix; Intron, Seongnam, Korea), according the manufacturer's instructions. Specific primers for each gene (Table 1) were designed using Primer Express Software (Applied Biosystems, Carlsbad, CA, USA). The real-time reverse transcription polymerase chain reaction reaction mixture consisted of 10 ng of reverse-transcribed total RNA, 167 nM forward and reverse primers, and PCR Master Mix (2X) in a fi nal volume of 20 μL. Polymerase chain reaction was carried out in 48-well plates using the ABI Step One Plus Sequence Detection System (Applied Biosystems). All experiments were performed in triplicate.
RESULTS
Ginsenoside Rb 1 increased cell viability
To examine effect of Rb 1 on primary chondrocytes, the cell viability of the chondrocytes in the presence of Rb 1 or H 2 O 2 was determined. As shown in Fig. 1A , the chondrocytes exposed to ginsenoside Rb 1 at various concentrations (0 to 400 μM) did not exhibit signifi cant toxicity over a period of 24 h. The percentage of viable cells was Therefore, all subsequent experiments were carried out using chondrocytes that had been pretreated for 1 h with 50 or 100 μM ginsenoside Rb 1 and then exposed to 500 μM H 2 O 2 for 24 h.
Ginsenoside Rb 1 decreased the release of interleukin-1β and tumor necrosis factor-α IL-1β and TNF-α are pro-infl ammatory cytokines that are induced by various cell stimulators. The absorbances measured by IL-1β and TNF-α ELISA kits were converted into percentages of the control absorbances. As shown in Fig. 2A To further analyze the effect of Rb 1 on nitric oxygen production and iNOS expression, cells were treated with Rb 1 prior to H 2 O 2 treatment. As shown in Fig. 3A , ginsenoside Rb 1 dose-dependently suppressed the NO production induced by H 2 O 2 to approximately 250% at the highest concentration. The activity of iNOS was determined by immunoblotting (Fig. 3B) , which revealed the dose-dependent suppression of iNOS protein expression. These results indicate that ginsenoside Rb 1 suppressed the production of NO (p<0.01) and iNOS expression (p<0.05) in H 2 O 2 -treated chondrocytes.
Ginsenoside Rb 1 suppressed cellular reactive oxygen species production
The level of ROS in ginsenoside Rb 1 -and H 2 O 2 -treated chondrocytes was measured (Fig. 4) . The H 2 O 2 -treated cells showed the greatest increase in cellular ROS production (up to threefold) compared with the control. The cells exposed to the 1-hour pretreatment with 100 μM ginsenoside Rb 1 and to H 2 O 2 exhibited signifi cantly suppressed production of ROS (down to threefold, p<0.01) compared with the H 2 O 2 -only group. This result indicates that ginsenoside Rb 1 significantly suppressed ROS production in H 2 O 2 -treated chondrocytes.
Ginsenoside Rb 1 improved chondrogenic genes and suppressed chondrogenic inflammatory genes
H 2 O 2 induced the expression of the chondrogenic inflammation factors MMP1 and MMP13 in chondrocytes. Additionally, H 2 O 2 reduced the expression of type II collagen and SOX9, proteoglycans produced by chondrocytes with normal phenotypes. Thus, while H 2 O 2 increased MMP1 and MMP13 expression and decreased type II collagen and SOX9 expression, chondrocytes pretreated with 100 μM ginsenoside Rb 1 for 1 h prior to exposure to H 2 O 2 showed a different gene expression pattern (Fig. 5 ). After the addition of H 2 O 2 for 12 h, cultures that had been pretreated with ginsenoside Rb 1 exhibited decreased MMP1 and MMP13 expression levels (from 2.5 to 1.4 fold, p<0.05, and 1.5 to 1.2 fold, p<0.05, and 100 μM ginsenoside Rb 1 in the presence of 500 μM H 2 O 2 , and incubated for 0.5 h. Measurement of reactive oxygen species (ROS) production was performed as described in Materials and Methods section. Data are expressed as mean±SEM of three independent experiments, **p<0.01. Vol. 36, No. 2, 161-168 (2012) respectively) compared with cultures treated with H 2 O 2 alone. The reductions in the expression levels of type II collagen and SOX9 were restored by pretreatment with 100 μM ginsenoside Rb 1 compared with H 2 O 2 -only treated cells. These results indicate that ginsenoside Rb 1 attenuated chondrogenic infl ammation and improved the expression of proteoglycans that protect against H 2 O 2 -induced infl ammation in rat chondrocytes.
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DISCUSSION
The abnormal maturation and ossifi cation of articular chondrocytes play a central role in the pathogenesis of OA [15] . The pathology of OA involves various risk factors. Among these risk factors, oxidative stress and free radicals have been suggested to be important factors involved in OA [16] .
Previously published studies have demonstrated that OA chondrocytes have a high lipoxidative activity [17] . Furthermore, the antioxidant capacity is diminished by aging, and increased lipid peroxidation has been observed in OA patients. These studies showed that oxidative stress plays an important role in the pathology of OA [18] .
Excessive oxidative stress causes damage to DNA, lipids, and proteins and induces concomitant cellular damage [19] . H 2 O 2 is a key intermediate in superoxide anion metabolism [3] . Several studies have shown that the activity of catalase (a free radical scavenger) is decreased in arthritic joints, including joints affected by OA [4] . Moreover, the major infl ammatory cytokines IL-1β and TNF-α are highly expressed in OA. These cytokines downregulate the enzymatic antioxidant defenses in chondrocytes, resulting in the transient accumulation of H 2 O 2 [5, 20] . Therefore, using antioxidants to protect against free radicals may be important the regulation of OA. In this study, H 2 O 2 was employed to create an oxidative stress environment, and the effect of ginsenoside Rb 1 on the regulation of various genes in H 2 O 2 -stimulated chondrocytes was evaluated. A previous study demonstrated the anti-oxidative and anti-inflammatory effects of ginsenoside Rb 1 on 6-hydroxydopamine-treated human dopaminergic cells [21] and lipopolysaccharidetreated RAW 264.7 cells [22] . Our results revealed that ginsenoside Rb 1 exhibits strong cytoprotective effects in a dose-dependent manner (Fig. 1B) . The levels of the H 2 O 2 -elicited proinflammatory cytokines IL-1β and TNF-α were significantly inhibited by ginsenoside Rb 1 (Fig. 2) . Chondrocytes in the articular cavity might be the primary source of NO because they can generate more than any other cell type. Compared with the control, the chondrocytes in our in vitro model of OA produced signifi cantly greater levels of NO (Fig. 3A) . NO is generated by activated iNOS during inflammatory processes [23] . Our results showed that H 2 O 2 -elicited NO, iNOS, and ROS production were significantly suppressed by ginsenoside Rb 1 (Figs. 3 and 4) . NO can induce intracellular signal transduction and inflammatory gene activation. Furthermore, NO can inhibit the synthesis of collagens and proteoglycans and can increase MMP activity in chondrocytes [24] . Pathologic changes include the decreased synthesis of ECM proteins, and the local accumulation of destructive enzymes was observed in H 2 O 2 -stimulated chondrocytes [25] . Drugs for the treatment of degenerative diseases of articular joints may be developed by increasing the synthesis of ECM molecules such as type II collagen and SOX9 and by inhibiting destructive enzymes such as MMPs [26] . Among members of the MMP superfamily, MMP1 and MMP13 have been shown to degrade type II collagen in OA. Our results revealed that ginsenoside Rb 1 antagonized chondrogenic infl ammatory genes (MMP1 and MMP13) and agonized chondrogenic genes (type II collagen and SOX8) to protect against H 2 O 2 -induced oxidative stress (Fig. 5) . These results suggest that ginsenoside Rb 1 has potential for use as a therapeutic agent for OA due to this compound's anti-infl ammatory effects.
Our study evaluated the cytoprotective effects of ginsenoside Rb 1 on H 2 O 2 -stimulated chondrocytes. By detecting major proteins and infl ammatory genes related to chondrogenic enzymes, we determined that ginsenoside Rb 1 plays a protective role in articular chondrocytes. In conclusion, the present study demonstrated the protective effect of ginsenoside Rb 1 on chondrocytes and provided new insight into the medicinal qualities of ginseng extracts. Our results suggest the possibility of including ginsenoside Rb 1 in therapeutic interventions for OA.
